Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Toxicol ; 90(10): 2531-62, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27439414

ABSTRACT

The GRACE (GMO Risk Assessment and Communication of Evidence; www.grace-fp7.eu ) project was funded by the European Commission within the 7th Framework Programme. A key objective of GRACE was to conduct 90-day animal feeding trials, animal studies with an extended time frame as well as analytical, in vitro and in silico studies on genetically modified (GM) maize in order to comparatively evaluate their use in GM plant risk assessment. In the present study, the results of a 1-year feeding trial with a GM maize MON810 variety, its near-isogenic non-GM comparator and an additional conventional maize variety are presented. The feeding trials were performed by taking into account the guidance for such studies published by the EFSA Scientific Committee in 2011 and the OECD Test Guideline 452. The results obtained show that the MON810 maize at a level of up to 33 % in the diet did not induce adverse effects in male and female Wistar Han RCC rats after a chronic exposure.


Subject(s)
Animal Feed , Food, Genetically Modified/toxicity , Health Status , Plants, Genetically Modified/toxicity , Zea mays/genetics , Animal Feed/standards , Animal Feed/toxicity , Animals , Female , Male , Rats, Inbred Strains , Risk Assessment , Toxicity Tests, Chronic
2.
Arch Toxicol ; 88(12): 2289-314, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25270621

ABSTRACT

The GMO Risk Assessment and Communication of Evidence (GRACE; www.grace-fp7.eu ) project is funded by the European Commission within the 7th Framework Programme. A key objective of GRACE is to conduct 90-day animal feeding trials, animal studies with an extended time frame as well as analytical, in vitro and in silico studies on genetically modified (GM) maize in order to comparatively evaluate their use in GM plant risk assessment. In the present study, the results of two 90-day feeding trials with two different GM maize MON810 varieties, their near-isogenic non-GM varieties and four additional conventional maize varieties are presented. The feeding trials were performed by taking into account the guidance for such studies published by the EFSA Scientific Committee in 2011 and the OECD Test Guideline 408. The results obtained show that the MON810 maize at a level of up to 33 % in the diet did not induce adverse effects in male and female Wistar Han RCC rats after subchronic exposure, independently of the two different genetic backgrounds of the event.


Subject(s)
Animal Feed , Food, Genetically Modified/toxicity , Plants, Genetically Modified/toxicity , Zea mays/genetics , Administration, Oral , Animal Feed/standards , Animal Feed/toxicity , Animals , Body Weight , Consumer Product Safety , Diet , Female , Male , Organ Size , Rats, Inbred Strains , Research Design , Risk Assessment , Toxicity Tests, Subchronic
3.
Brain Res ; 1568: 10-20, 2014 Jun 03.
Article in English | MEDLINE | ID: mdl-24792309

ABSTRACT

Chronic cerebral hypoperfusion and aging can be related to vascular dementia manifested by the decline in cognitive abilities and memory impairment. The identification of specific biomarkers of vascular disorder in early stages is important for the development of neuroprotective agents. In the present study, a three-vessel occlusion (3-VO) rat model of vascular dementia in the middle-aged rat brain was used to investigate the effect of global cerebral hypoperfusion. A multimodal study was performed using magnetic resonance spectroscopy, MR-microimaging, histology and behavioral tests. Our measurements showed a signal alteration in T2-weighted MR images, the elevation of T2 relaxation times and histologically proven neural cell death in the hippocampal area, as well as mild changes in concentration of proton and phosphorus metabolites. These changes were accompanied by mild behavioral alterations in the open field and slightly decreased habituation. The analysis of the effects of vascular pathology on cognitive functions and neurodegeneration can contribute to the development of new treatment strategies for early stages of neurodegeneration.


Subject(s)
Brain/pathology , Brain/physiopathology , Dementia, Vascular/pathology , Dementia, Vascular/physiopathology , Animals , Cell Death , Cerebrovascular Circulation , Disease Models, Animal , Habituation, Psychophysiologic , Magnetic Resonance Imaging , Magnetic Resonance Spectroscopy , Male , Motor Activity , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...